Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aptose Biosciences (APTO)
NASDAQ:APTO
RESEARCH TOOLSreports
Aptose Biosciences (APTO) Stock Price & Analysis
1,178 Followers
APTO Stock Chart & Stats
Day’s Range$1.15 - $1.24
52-Week Range― - ―
Previous Close$1.22
Volume47.11K
Average Volume (3M)N/A
Market Cap
$18.98M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 07, 2024EPS Estimate
-$1.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$12.00Price Target Upside934.48% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Aptose Biosciences News
PremiumCompany Announcements
Aptose Biosciences Expands AML Treatment Trials
PremiumCompany Announcements
Aptose Biosciences Unveils Upcoming Financials
PremiumCompany Announcements
Aptose Biosciences Clarifies Regulatory Compliance Measures
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
APTO FAQ
What was Aptose Biosciences’s price range in the past 12 months?
Currently, no data Available
What is Aptose Biosciences’s market cap?
Currently, no data Available
When is Aptose Biosciences’s upcoming earnings report date?
Aptose Biosciences’s upcoming earnings report date is May 07, 2024 which is in 11 days.
How were Aptose Biosciences’s earnings last quarter?
Aptose Biosciences released its earnings results on Mar 26, 2024. The company reported -$1.3 earnings per share for the quarter, beating the consensus estimate of -$1.595 by $0.295.
Is Aptose Biosciences overvalued?
According to Wall Street analysts Aptose Biosciences’s price is currently Undervalued.
Does Aptose Biosciences pay dividends?
Aptose Biosciences does not currently pay dividends.
What is Aptose Biosciences’s EPS estimate?
Aptose Biosciences’s EPS estimate is -$1.1.
How many shares outstanding does Aptose Biosciences have?
Currently, no data Available
What happened to Aptose Biosciences’s price movement after its last earnings report?
Aptose Biosciences reported an EPS of -$1.3 in its last earnings report, beating expectations of -$1.595. Following the earnings report the stock price went down -6.25%.
Which hedge fund is a major shareholder of Aptose Biosciences?
Among the largest hedge funds holding Aptose Biosciences’s share is Carlson Capital LP. It holds Aptose Biosciences’s shares valued at 246K.
---
Aptose Biosciences Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.00 (934.48% Upside)
$12.00 (934.48% Upside)
Blogger Sentiment
Neutral
APTO Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 10.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.5%
Last 30 Days ▲ 8.3%
Last 30 Days ▲ 8.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-83.11%
12-Months-Change
Fundamentals
Return on Equity
-293.96%
Trailing 12-Months
Asset Growth
-74.54%
Trailing 12-Months
Company Description
Aptose Biosciences
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
---
APTO Earnings Call
Q4 2024
0:00 / 0:00
---
APTO Stock 12 Months Forecast
Average Price Target
$12.00
▲(934.48% Upside)
Technical Analysis
Best Analysts Covering APTO
1 Year
1 Year Success Rate
4/20 ratings generated profit
1 Year Average Return
-12.48%
reiterated a buy rating last month
Copying John Newman's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -12.48% per trade.
---